Despite decades of research effort directed towards understanding the basic biology, etiology, prevention, and means of treatment of malignant disease, cancer remains one of the most serious health problems for the US population. Over 1.4 million new cancer cases are diagnosed each year and over one half million persons will die as a consequence. Approximately 40% of men and 33% of women in the US will develop cancer by their 85th birthday. The need for this interdisciplinary training program in cancer epidemiology and biostatistics has never been greater. The virtual explosion in recent years of new knowledge regarding the biological mechanisms underlying the development of cancer, particularly at the molecular level and in regard to the role of genetic determinants, continues to accelerate, presenting both new challenges and unprecedented opportunities within the public health sciences field to translate this knowledge from new technologies into significant improvements in incidence and mortality from cancer. The purpose of the University of Washington's long-standing training program in cancer epidemiology and biostatistics is to provide the highest level of training and experience in these closely-related disciplines that will enable the trainee to address this problem through the conduct of high quality cancer research. The program is housed in the Departments of Epidemiology and Biostatistics in the School of Public Health of the University of Washington. All of the predoctoral trainees and most of the postdoctoral trainees have been enrolled in the graduate programs that these departments offer. Much of the training also takes place at our affiliated institution, the Fred Hutchinson Cancer Research Center. For the new award period we propose to train seven predoctoral students (enrolled in the epidemiology or biostatistics PhD program, and four postdoctoral trainees (most within a few years of their doctorate). The Training Grant has been in operation now for 35 years. Of the approximately 160 trainees that have entered through the program, most have had backgrounds in the health professions, science, and/or mathematics. Our program's record has been a good one. With very few exceptions, all positions on the training grant have been filled, and the overwhelming majority of the trainees who began the program have completed it. In addition, nearly all trainees who completed the program have pursued careers in science or public health, and they have produced a large quantity of noteworthy cancer research, both while they were in the training program and afterwards. The past award period has seen a significant increases in the number of trainees from underrepresented minority groups compared to past years. A minor change in this revised application is a new co-Director representing the Biostatistics Department.

Public Health Relevance

Cancer remains a major health problem in the US, killing over 500,000 persons per year. In recent years, rapid progress in technology has provided the means to generate new knowledge relevant to the causes of cancer, including inherited predisposition, as well as means of early detection of cancer, when it is most curable. The proposed training program will provide graduate students and recent graduates from medical and doctoral programs with a high level of training and experience to enable them to make significant contributions in their careers to the prevention and treatment of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009168-39
Application #
8883395
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Lim, Susan E
Project Start
1980-07-01
Project End
2016-06-30
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
39
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Washington
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Coghill, Anna E; Schenk, Jeannette M; Mahkoul, Zeina et al. (2018) Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda. AIDS 32:505-512
Dai, James Y; Wang, Xiaoyu; Buas, Matthew F et al. (2018) Whole-genome sequencing of esophageal adenocarcinoma in Chinese patients reveals distinct mutational signatures and genomic alterations. Commun Biol 1:174
Baglia, Michelle L; Tang, Mei-Tzu C; Malone, Kathleen E et al. (2018) Family History and Risk of Second Primary Breast Cancer after In Situ Breast Carcinoma. Cancer Epidemiol Biomarkers Prev 27:315-320
Buas, Matthew F; Gu, Haiwei; Djukovic, Danijel et al. (2017) Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma. Metabolomics 13:
Onega, Tracy; Lee, Christoph I; Benkeser, David et al. (2016) Travel Burden to Breast MRI and Utilization: Are Risk and Sociodemographics Related? J Am Coll Radiol 13:611-9
Lowry, Sarah J; Kapphahn, Kris; Chlebowski, Rowan et al. (2016) Alcohol Use and Breast Cancer Survival among Participants in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev 25:1268-73
Kocarnik, Jonathan M; Chan, Andrew T; Slattery, Martha L et al. (2016) Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer 139:1065-72
Fu, Benjamin C; Randolph, Timothy W; Lim, Unhee et al. (2016) Characterization of the gut microbiome in epidemiologic studies: the multiethnic cohort experience. Ann Epidemiol 26:373-9
Passarelli, Michael N; Newcomb, Polly A (2016) Blood Lipid Concentrations and Colorectal Adenomas: A Systematic Review and Meta-Analysis of Colonoscopy Studies in Asia, 2000-2014. Am J Epidemiol 183:691-700
Domingo, Laia; Hofvind, Solveig; Hubbard, Rebecca A et al. (2016) Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain. Eur Radiol 26:2520-8

Showing the most recent 10 out of 235 publications